These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 19729902

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Osteoprotegerin and RANKL serum levels and their relationship with serum ghrelin in children with chronic renal failure and on dialysis.
    Ozkaya O, Buyan N, Bideci A, Gonen S, Ortac E, Fidan K, Cinaz P, Söylemezoğlu O.
    Nephron Clin Pract; 2007; 105(4):c153-8. PubMed ID: 17259742
    [Abstract] [Full Text] [Related]

  • 3. Plasma osteoprotegerin is associated with mortality in hemodialysis patients.
    Morena M, Terrier N, Jaussent I, Leray-Moragues H, Chalabi L, Rivory JP, Maurice F, Delcourt C, Cristol JP, Canaud B, Dupuy AM.
    J Am Soc Nephrol; 2006 Jan; 17(1):262-70. PubMed ID: 16280472
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.
    Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M, Negrao AP.
    Nephrol Dial Transplant; 2004 Jun; 19(6):1480-8. PubMed ID: 15034154
    [Abstract] [Full Text] [Related]

  • 6. Vascular calcification and cardiovascular outcome in dialysis patients: the role of gene polymorphisms.
    Cozzolino M, Biondi ML, Galassi A, Cusi D, Brancaccio D, Gallieni M.
    Blood Purif; 2010 Jun; 29(4):347-51. PubMed ID: 20357434
    [Abstract] [Full Text] [Related]

  • 7. Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease.
    Kiechl S, Schett G, Schwaiger J, Seppi K, Eder P, Egger G, Santer P, Mayr A, Xu Q, Willeit J.
    Circulation; 2007 Jul 24; 116(4):385-91. PubMed ID: 17620507
    [Abstract] [Full Text] [Related]

  • 8. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?
    Pertosa G, Simone S, Ciccone M, Porreca S, Zaza G, Dalfino G, Memoli B, Procino A, Bonomini M, Sirolli V, Castellano G, Gesualdo L, Ktena M, Schena FP, Grandaliano G.
    Am J Kidney Dis; 2009 Mar 24; 53(3):467-74. PubMed ID: 19167798
    [Abstract] [Full Text] [Related]

  • 9. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV, Lahiri A, Lim E, Hopkins D, Corder R.
    J Am Coll Cardiol; 2006 May 02; 47(9):1850-7. PubMed ID: 16682312
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y, Onouchi T, Ikeda T, Adachi J, Tamura Y, Horiuchi T.
    Gerontology; 2009 May 02; 55(3):275-80. PubMed ID: 19158438
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G, Charra B, Chazot C.
    J Ren Nutr; 2008 Sep 02; 18(5):395-9. PubMed ID: 18721733
    [Abstract] [Full Text] [Related]

  • 13. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.
    Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, Takishita S.
    Clin Exp Nephrol; 2004 Mar 02; 8(1):54-8. PubMed ID: 15067517
    [Abstract] [Full Text] [Related]

  • 14. Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients.
    Nishiura R, Fujimoto S, Sato Y, Yamada K, Hisanaga S, Hara S, Nakao H, Kitamura K.
    Am J Nephrol; 2009 Mar 02; 29(3):257-63. PubMed ID: 18802328
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism.
    Baek KH, Oh KW, Lee WY, Tae HJ, Rhee EJ, Han JH, Cha BY, Kim YJ, Lee KW, Son HY, Kang SK, Kim CC, Kang MI.
    Bone; 2006 Dec 02; 39(6):1352-60. PubMed ID: 16905375
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Coronary calcification improves cardiovascular risk prediction in the elderly.
    Vliegenthart R, Oudkerk M, Hofman A, Oei HH, van Dijck W, van Rooij FJ, Witteman JC.
    Circulation; 2005 Jul 26; 112(4):572-7. PubMed ID: 16009800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.